Jaguar animal health to host treatment forum for veterinarians about chemotherapy-induced diarrhea (cid) in dogs on sunday, march 6th, during the western veterinary conference (wvc) in las vegas

Canalevia™-ca1, which received conditional approval from the fda on december 21, 2021, is the first and only treatment for cid in dogs to receive any type of approval from the fda u.s. veterinarians, veterinary oncologists, and members of the media can click here to register for the cid treatment forum san francisco, ca / accesswire / march 1, 2022 / jaguar health, inc. (nasdaq:jagx), under its jaguar animal health tradename for the veterinary market, today announced that the company is hosting a treatment forum for veterinarians about chemotherapy-induced diarrhea (cid) in dogs at the mandalay bay resort and casino in las vegas on sunday, march 6, 2022 from 5:30 pm - 7:30 pm pacific time during the western veterinary conference (wvc), which is being held at the same location. noted veterinary oncologist dr. craig a.
JAGX Ratings Summary
JAGX Quant Ranking